The present invention concerns benzodioxane-piperidine with general formula I: wherein notably: - R1 represents one or more identical or different substituent(s) on the benzene ring, each independently representing a hydrogen or halogen atom, or a C1-4 alkyl group, or a C1-4 alkoxy group or a C1-4 hydroxyalkyl group or a C1-4 alkylcarbonyl or an alkoxycarbonyl group or an OH group or an SO2R group with R alkyl, or a CN group, or a CF3 group, or an OCF 3 group； - n = 1, 2 or 3； - m = 0 or 1, and - R2 represents one or more identical or different substituent(s) on the oxazolidinone or morpholinone ring, each independently representing: a hydrogen atom, a C1-4 alkyl group, or a C1-4 alkoxy group, or a C1-4 hydroxyalkyl group, or an alkylcarbonyl group, or an alkoxycarbonyl group, or an alkoxyphenyl group.本發明有關具有通式I之苯并二烷-哌啶：其中值得注意的是：- R1代表一或多種在苯環上之相同或相異的取代基，各自獨立地代表氫或鹵素原子，或C1-4烷基基團，或C1-4烷氧基基團或C1-4烴烷基基團或C1-4烷羰基或烷氧羰基基團或OH基團或具有R為烷基之SO2R基團，或CN基團，或CF3基團，或OCF3基團；- n=1、2或3；- m=0或1，以及- R2代表一或多種在唑烷酮或嗎啉酮環上之相同或相異的取代基，各自獨立地代表：氫原子、C1-4烷基基團，或C1-4烷氧基基團，或C1-4羥烷基基團，或烷羰基基團，或烷氧羰基基團，或烷氧苯基基團。
